S
XERS icon

SignatureFD’s Xeris Biopharma Holdings XERS Stock Holding History

SignatureFD’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5K Hold
631
– – ﹤0.01% 2866
2026
Q1 		$3.66K Sell
631
-89
-12% -$590 ﹤0.01% 2879
2025
Q4 		$5.65K Buy
720
+89
+14% +$700 ﹤0.01% 2646
2025
Q3 		$5.14K Hold
631
– – ﹤0.01% 2653
2025
Q2 		$2.95K Buy
631
+240
+61% +$1.1K ﹤0.01% 2759
2025
Q1 		$2.15K Buy
+391
New +$1.58K ﹤0.01% 2854
2022
Q2 		– Sell
-1,445
Closed -$4K – 3366
2022
Q1 		$4K Buy
+1,445
New +$3.53K ﹤0.01% 2628

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SignatureFD's XERS Position: Q2 2026 in Review

SignatureFD held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 631 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #2866.

SignatureFD first reported a position in XERS in Q1 2022 and has held it in 7 quarters since. The position peaked at $5.65K in Q4 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • SignatureFD held 631 shares of Xeris Biopharma Holdings worth $5K as of Q2 2026.
  • SignatureFD left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2866 holding.
  • SignatureFD first reported a position in Xeris Biopharma Holdings in Q1 2022 and has held it in 7 quarters since.
  • SignatureFD's Xeris Biopharma Holdings position peaked at $5.65K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.